We Built an AI That Answers at 2 AM. Here's What It Taught Us.

Imagine someone sitting alone at midnight, staring at a lump they discovered in the shower two hours ago. They've already opened and closed three browser tabs. They're not ready to call a doctor. They're not ready to say the word out loud to anyone who knows them. But they're scared enough to type something into Google.

That person is real. That moment happens every single night.

For years, the Testicular Cancer Foundation had no way to be there for them. We had a website. We had educational resources. We had staff who cared deeply. But we didn't have a way to show up at 2 AM, in real time, for someone sitting in that exact room, asking that exact question, and needing a response that felt honest rather than clinical.

That changed in January 2026, when we launched the TC Navigator.

What We Built

The TC Navigator is an AI agent embedded directly into testicularcancer.org, built in partnership with Chatbase. It is trained on TCF's own clinical content: information about symptoms, diagnosis, treatment protocols, survivorship, and caregiver support. It does not pull answers from the open internet. It draws from what we have spent years building and verifying, supplemented by vetted third-party clinical sources curated by our team. That human-in-the-loop curation is what separates a capable AI tool from a trustworthy one, and it makes that knowledge available to anyone, at any hour, in any language, without a waitlist or a co-pay or an awkward conversation to initiate.

In its first 30 days, the Navigator handled 60 conversations and answered 484 individual questions. Twenty-eight percent of those conversations came from outside the United States, reaching patients in Brazil, Croatia, Germany, India, Nigeria, Poland, Turkey, Vietnam, and the UK. It responded in Portuguese, Turkish, German, and Spanish without any configuration on our end. None of this required a single staff member to type a single word.

That is not a small thing for a lean nonprofit.

What the Data Revealed

The statistics told one story. The conversations told another.

More than 20% of all sessions began with some version of "I feel a lump." For many of those users, the Navigator was the first cancer-related resource they had ever consulted. Not a doctor. Not a friend. An AI on a nonprofit's website, at an hour when no one else was available.

That finding stopped us. It confirmed something we had long suspected but couldn't prove: the barrier to early detection is not access to information. It's the silence before someone is ready to ask. Men, especially young men, will avoid the question until the fear of not knowing becomes greater than the fear of knowing. What the TC Navigator does is lower that threshold. It is available without judgment, without scheduling, without the social weight of telling another human being what you are worried about.

The heaviest usage came between 4 PM and midnight EST, exactly when clinical staff are unavailable and anxiety tends to peak. One Brazilian survivor, five months out from chemotherapy, sent 157 messages in a single session, working through CT scan results, cross-referencing NCCN and EAU clinical guidelines, and trying to make sense of what his future looked like. The Navigator stayed with him through every question.

Caregivers made up roughly one in ten users. Partners and parents, navigating a diagnosis that belonged to someone else, looking for sperm banking timelines and financial assistance resources and language for a conversation they didn't know how to start.

What This Means for Healthcare and Technology

We are not a technology organization. We are a mission-driven nonprofit with a small team and a large problem. What Chatbase made possible was the deployment of a genuinely capable clinical tool without an engineering team, without a lengthy implementation process, and without compromising on data security. The platform holds SOC 2 Type II certification and is fully GDPR compliant, which meant we could serve users in Germany and Croatia and Poland without additional legal exposure.

The underlying architecture matters here for anyone in the healthcare or technology space evaluating AI for patient-facing use. The Navigator uses retrieval-augmented generation, meaning it does not fabricate responses. It retrieves information from TCF's verified content and generates answers grounded in that specific source material. That is why it can accurately discuss AFP markers, RPLND surgical protocols, and BEP chemotherapy regimens. It is not guessing. It is drawing from what we know, translated into language that meets someone where they are.

For organizations working at the intersection of health and technology, this is the model worth paying attention to. Not AI as a novelty. Not AI as a cost-cutting measure. AI as infrastructure for presence, the ability to show up consistently and accurately for people who need you at moments you cannot staff.

What We Learned

Three things stood out from our first months of data.

The demand existed before the tool did. We did not create a new audience with the TC Navigator. We finally showed up for one that had been searching and finding nothing adequate. Any organization asking whether there is demand for this kind of support should look at its own search traffic and incoming email volume. The signal is already there.

The gaps in our knowledge base became visible immediately. Conversations surfaced content areas we had underserved: post-treatment anxiety, hormonal replacement after orchiectomy, fertility preservation timelines, and caregiver-specific resources. An AI tool does not just serve your audience. It shows you, at scale, what your audience actually needs.

An imperfect tool that exists is more useful than a perfect one still being built. We launched with gaps. We launched anyway. In its first month, the Navigator delivered 484 answers to people who would otherwise have had none.

Testicular cancer is the most common cancer in men between 15 and 35. Its survival rate exceeds 95% when caught early. The obstacle has never been treatment. It has been the silence before someone asks for help.

The TC Navigator exists to break that silence.

If you or someone you know has questions about testicular cancer, symptoms, diagnosis, or life after treatment, the TC Navigator is available now at testicularcancer.org/navigator. No appointment. No waitlist. Any hour.